We compared the biological effects of the CXC chemokine SDF-1␣ on immunomagnetically purified CD34 ؉ cells isolated from human normal bone marrow (NBM), leukapheresis products (LP) and patients with chronic myeloid leukaemia (CML). LP CD34 
Introduction
Chemokines are a family of 8-to 10-kDa proteins with 20-70% homology in amino acid sequences. Over 50 different members have been identified to date and their structural and biological properties have been reviewed in a number of recent articles. [1] [2] [3] Chemokines can be subdivided into at least four different subfamilies on the basis of the relative position of their cysteine residues. 3 The largest families are the ␣ and ␤ chemokines, the former being characterised by an intervening residue (X) separating the first two cysteine residues (C) thus also designated CXC-chemokines. 3, 4 Chemokines are produced by an array of stromal cell types including endothelial cells, 5 macrophages 6 and fibroblasts 7 in response to proinflammatory stimuli. 8 Members of the chemokine family have distinct but overlapping biological activities that include the regulation of leukocyte trafficking, 3,9,10 modulation of tumour growth 2 and angiogenesis. [11] [12] [13] Also, some of these chemokines, including the CC-chemokine macrophage inflammatory protein-1␣ (MIP-1␣) and the CXC chemokine stroma-derived factor-1␣ (SDF-1␣), have direct growth inhibitory effects on haemopoietic progenitor cells in vivo [14] [15] [16] and in vitro. [17] [18] [19] SDF-1␣ was initially identified as a growth factor for B cell progenitors and as a chemotactic factor for T cells and monocytes. [20] [21] [22] The biological effects of SDF-1␣ are mediated by the chemokine receptor CXCR-4, 22, 23 which belongs to the seven-transmembrane-spanning family of G-protein-coupled receptors. CXCR-4 is constitutively expressed on a wide array of haemopoietic cells including immature CD34
ϩ haemopoietic progenitor cells (HPC), lymphocytes and monocytes. [23] [24] [25] [26] Recent data generated in gene knockout experiments 27, 28 and studies employing neutralizing antibodies to CXCR-4 26 suggest an important role of SDF-1␣/CXCR-4 in HPC migration and mobilisation/engraftment.
It has been shown that SDF-1␣ binding to its cognate receptor is associated with transient elevations of intracellular calcium levels [Ca 2ϩ ] i , which has been used as an indicator of receptor activation. 19 The signal transduction pathways further downstream of the receptors have only been partially elucidated. 29, 30 We and others have previously shown that the growth suppressive effect of MIP-1␣ is not observed in primitive progenitor cells from patients with chronic myeloid leukaemia (CML), [31] [32] [33] an acquired clonal haemopoietic stem cell disease characterised by the 9:22 translocation which results in the expression of the bcr/abl protein tyrosine kinase (PTK). 34 This aberrant MIP-1␣ response in CML haemopoietic cells appeared to be due to defects in the signal transduction pathways downstream of the MIP-1␣-receptors. 35 Recent data by Salgia et al 36 showed that p210 bcr/abl transformed haemopoietic cell lines become refractory to the chemotactic effects of SDF-1␣. In the present study we have investigated the biological responsiveness of primary CML HPC to SDF-1␣. In particular, studies on SDF-1␣-induced alterations of CML CD34 ϩ cell migration in transwell chemotaxis systems, proliferation of these cells in standard colony-forming cell (CFC) assays and intracellular calcium mobilisation were performed. Furthermore, we examined the constitutive expression and regulation of CXCR-4 in CML HPC.
Materials and methods

Patients and cells
Normal bone marrow (NBM) was obtained from donations for allogeneic transplantation and leftovers of routine diagnostic marrow aspirations from haematologically normal patients (n = 20). Leukapheresis products (LP) were obtained from 14 patients with haematological malignancies or solid tumors (nine multiple myeloma, one acute lymphoblastic leukaemia, one chronic lymphatic leukaemia, one breast cancer, one Hodgkin's disease and one teratoma). Peripheral blood (n = 15) and bone marrow (n = 18) samples were obtained from 28 patients with chronic phase (cP) CML and six patients in blastic crisis (BC) of the disease (four patients with flow cytometrically confirmed B-lymphoblastic crisis and two patients with myeloid blastic crisis). Of the cP CML patients, 9/29 (31%) received hydroxyurea, whereas the remaining patients were untreated. Similarly, BC CML patients were untreated at the time of sample acquisition. All samples were taken with appropriate informed consent from the patients according to institutional guidelines. In HU-treated patients the drug was discontinued at least 3 days before bone marrow aspiration. Blood and bone marrow samples were collected in sterile tubes containing preservative-free heparin.
Isolation of mononuclear and CD34
ϩ cells
Mononuclear cells (MNC) were isolated by centrifugation on Ficoll-Hypaque (Lymphoprep, 1.077 g/ml; Nycomed, Birmingham, UK) at 400 g for 25 min. CD34 ϩ cells from patients with CML and patients undergoing peripheral stem cell collections were isolated using the Mini-MACS immunomagnetic separation system (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions.
In vitro two-chamber migration assay
This assay was performed as previously described 37 with minor modifications. Briefly, 100 l of migration medium (IMDM, 1% (w/v) BSA (Sigma, Deisenhofen, Germany)) containing 1.5 × 10 5 CD34 ϩ cells were added to the upper chamber of a Costar Transwell (Cambridge, MA, USA; 6.5 mm, 5 m pore; a 5 m pore was shown in preliminary experiments to be optimal for CD34 ϩ cells), and 600 l migration medium supplemented with various amounts of rhuSDF-1␣ (R&D Systems, Abingdon, UK) was added to the lower chamber. Chambers were incubated at 37°C for 4 h in a 5% CO 2 in air atmosphere. Cells migrating into the lower chamber were counted in triplicate using a FACScan (Becton Dickinson, Heidelberg, Germany) with appropriate gating for 60 s at a high flow rate. Percent migration was determined by calculating the percentage of input cells migrating to the lower chamber (average events for 60 s Ϭ average input cell events × 100).
Clonogenic assays
Two to three thousand CD34 ϩ cells were plated as previously described. 38 Briefly, cells were added to a 1 ml mixture containing 30% (v/v) fetal calf serum (FCS), 10% (w/v) deionized BSA, 10% (v/v) 5637-conditioned medium, 2 units Epo and 1.35% (w/v) methylcellulose in Iscove's modified Dulbecco's medium (IMDM; Gibco Laboratories, Grand Island, NY, USA). After through mixing, cells were plated in triplicate and incubated for 14 days at 37°C in 5% CO 2 and 5% O 2 in nitrogen. Colonies of granulocyte-macrophage cells (CFC-GM) or erythroid cells (BFU-E) were assessed.
Suspension cultures
0.5-1 × 10 6 CD34 ϩ cells were cultured in 24-flat-bottom well plates in IMDM, 15% (v/v) FCS. Cells were incubated for 12 h in 5% CO 2 in air. At the beginning and the end of the culture period, cells were washed in PBS and subjected to two-colour Leukemia flow cytometry using CD34 and CXCR-4 antibodies to determine CXCR-4 surface expression.
FISH analysis of CD34
ϩ HPC for the presence of the bcr/abl oncogene CD34 ϩ cells isolated from four patients with de novo CML were recovered from the inoculated and the migrated cell fractions following the above described chemotaxis assay and spun on to glass slides using a cytocentrifuge. FISH studies were performed employing a bcr/abl-specific probe (LSI bcr/abl SpectrumGreen/SpectrumOrange; Vysis, Bergisch Gladbach, Germany). Slide preparation, probe hybridization and washes were performed according to the manufacturer's instructions and cells were mounted in medium containing DAPI and antifade solution. Slides were examined with an Olympus BX50 fluorescence microscope equipped with an appropriate filter set. A minimum of 100 cells per slide was evaluated. Bcr/abl-positive and -negative cells were discriminated using published criteria. 39 
Ca 2ϩ mobilisation assay
This assay was performed as previously described with minor modifications. 40 
Cell surface staining and flow cytometry
Heparinised pB and BM samples were prepared for flow cytometry by ammonium chloride erythrocyte lysis (Ortho- To detect internalisation of CXCR-4, immunomagnetically purified CML CD34 ϩ cells were incubated for 4 h at 37°C in the presence or absence of SDF-1␣ (500 ng/ml) in IMDM/15% FCS. Thereafter, cells were put on ice and analysed for CXCR-4 expression using flow cytometry.
The flow cytometer (FACScan; Becton Dickinson) was calibrated with CAliBRITE-3 beads (Becton Dickinson) and FACSComp Software (Becton Dickinson). Data acquisition and analysis were performed using CellQuest software (Becton Dickinson).
Statistical analysis
Data are expressed as mean ± s.e.m. The Student's t-test was used to compare results between the indicated experimental groups.
Results
SDF-1␣ is a chemoattractant for normal and CML CD34
ϩ HPC
We used a standard 4 h transwell chemotaxis assay to compare the migratory response of normal BM CD34 ϩ and LP CD34 ϩ with CD34 ϩ HPC isolated from the PB and BM of CML patients. SDF-1␣ induced a concentration-dependent chemotactic effect on normal and CML CD34 ϩ cells ( Figure  1a and b) . Over a concentration range from 0 to 100 ng/ml there was a marked SDF-1␣-induced migration response (P Ͻ 0.05), whereas a further concentration increase to 300 ng/ml did not result in statistically higher numbers of migrated CD34 ϩ cells (Figure 1a , 100vs 300 ng/ml, P = 0.2). At a SDF-1␣ concentration of 100 ng/ml LP CD34 ϩ cells exhibited a significantly stronger migration response than CML PB CD34 ϩ HPC (Figure 1b , P Ͻ 0.05). Moreover, circulating CML PB CD34 ϩ cells were less responsive to SDF-1␣ than their BM counterparts ( Figure 1 , P Ͻ 0.05). Comparing BM CML CD34 ϩ with NBM CD34 ϩ cells, there was a trend towards a stronger SDF-1␣ response in the latter group, but the observed differences did not reach statistical significance (P = 0.1). Spontaneous CD34 ϩ cell migration in the absence 
SDF-1␣ is an equipotent chemotactic stimulus for bcr/abl-positive and -negative CD34
ϩ cells in chimeric CML CD34 ϩ cell populations
In four cases (three PB and one BM sample) with de novo untreated CML (chronic phase at diagnosis) the percentage of bcr/abl-positive and -negative CD34 ϩ HPC in the inoculated and migrated fractions was quantified using fluorescent in situ hybridisation (FISH). The incidence of bcr/abl-positive CD34 ϩ cells in the inoculated (74.3 ± 6.9%) and migrated cell fractions (75.8 ± 9.1%) was similar (P Ͼ 0.05). The percentages of CD34
ϩ cells migrating to SDF-1␣ (100 ng/ml) in the CML PB and BM CD34 ϩ cell preparations were 3.6, 1.6, 2.8 and 11.0%, respectively.
Effects of SDF-1␣ on colony formation from normal and CML CD34
In Figure 3a and b, the effects of varying concentrations of SDF-1␣ on colony formation from CD34 ϩ cells isolated from CML PB, CML BM and LP are compared. The addition of SDF-1␣ to CD34
ϩ cell suspensions from all sources resulted in sig- 
Normal CD34
ϩ and CML CD34 ϩ HPC exhibit comparable CXCR-4 expression levels
The co-expression of the CD34 antigen and CXCR-4 was assessed flow cytometrically on cells isolated from the BM and PB of CML patients and compared to normal CD34 ϩ cells from NBM and LP. CXCR-4 expression was quantified as the percentage of CXCR-4-positive cells in the CD34 ϩ population as shown in Figure 4 . The majority of CD34 ϩ cells expressed CXCR-4 and no significant differences were observed between the four groups (P Ͼ 0.05; Figure 4 ). In nine CML and eight normal CD34 ϩ samples where both data on CXCR-4 expression levels and migration responses were available, regression analysis did not reveal a correlation between the two parameters (r 2 = 0.22 and 0.14 in normal and CML CD34 ϩ cells, respectively).
CXCR-4 is up-regulated in the course of human B-lymphopoiesis
CXCR-4 has previously been detected at similar levels on both phenotypically primitive and committed progenitors from fetal and adult sites. 23 There is a significant up-regulation of CXCR-4 as the cells develop from CD34 ϩ to more mature B lymphocytes ( Figure 5 
CXCR-4 is up-regulated on CD34
ϩ /CD19 ϩ /CD10 Figure 5 ). The SDF-1␣-induced migration response in this group was heterogenous in that two samples showed comparable numbers of migrated cells with those of the cP CML patients whereas one patient exhibited a four-fold stronger migratory response than the remaining BM CML CD34 ϩ cells (Table 1 and Figure 1b) .
SDF-1␣ down-modulates CXCR-4 surface expression on LP and CML CD34
After incubation (4 h at 37°C) with SDF-1␣ (500 ng/ml) CXCR-4 surface immunoreactivity on LP and CML CD34 ϩ cells was analysed by two-colour flow cytometry and quantified as mean fluorescence intensity (MFI). SDF-1␣ induced a profound statistically significant decrease of CXCR-4 surface expression on LP and CML CD34 ϩ HPC from baseline MFI levels of 11.9 ± 2.8 to 4.8 ± 1.3 (n = 3, P Ͻ 0.05) and 71.6 ± 19.7 to 15.5 ± 6.3 (P Ͻ 0.05, n = 4), respectively. CD34 ϩ
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Figure 3
Effects of SDF-1␣ on the proliferation of normal LP and CML colony-forming cells (BM CD34 + n = 6, PB CD34 + n = 2) in clonogenic methylcellulose cultures. 2000 to 3000 CD34
+ cells were cultured in the continous presence of SDF-1␣ at the indicated concentrations. Results of n (shown) experiments are expressed as the total numbers of colonies (CFC-GM, a; and BFU-E, b) generated from these cells in the percentage of untreated controls. Results obtained using LP CD34
+ cells have previously been published. 19 LP and CML control cultures contained 38 ± 9, 41 ± 11 CFC-GM and 270 ± 80, 138 ± 31 BFU-E, respectively.
Figure 4
Analysis of CXCR-4 expression by flow cytometry.
Constitutive expression of CXCR-4 on human CD34
+ cells from NBM, LP and the pB and BM of CML patients. Cells were double-stained with antibodies specific for the CD34 antigen and CXCR-4. Results are expressed as the percentage of CD34 + cells co-expressing CXCR-4 based on control cells stained with isotype matched irrelevant control antibodies. Horizontal bars denote the mean of n individual determinations. There were no significant differences between the four groups (P Ͼ 0.05). 
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SDF-1␣ induces calcium mobilisation in both normal and CML CD34
The capacity of SDF-1␣ to induce a rapid and transient rise of cytosolic Ca 2ϩ concentration [Ca 2ϩ ] i was assessed on purified NBM and CML CD34 ϩ preparations. SDF-1␣ induced a marked and rapid response in both CML and NBM CD34 ϩ cell preparations ( Figure 6 ).
Figure 6
Calcium responses of normal and CML CD34 + cells to SDF-1␣ (at 150 ng/ml). CD34
+ cells were loaded with indo-1 before chemokine stimulation. Details of the indo-1 staining protocol and flow cytomeric analysis are given in Materials and methods.
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Discussion
In the present study we investigated the biological responsiveness of CML haemopoietic progenitor cells to the CXC chemokine SDF-1␣. Using a standard 4 h transwell migration system 37 we showed that CML CD34 ϩ HPC exhibit a moderately reduced chemotactic response to SDF-1␣ in comparison to normal LP and BM CD34 ϩ cells. The observed differences reached statistical significance when circulating PB CML CD34 ϩ cells were compared to LP CD34 ϩ cells, whereas the migration response of CML BM CD34 ϩ was only slightly lower than in NBM CD34 ϩ cells (P Ͼ 0.05). Notably, the SDF-1␣-induced promigratory effect was significantly stronger in BMderived CML CD34
ϩ cells than in their circulating counterparts isolated from peripheral blood. This observation is consistent with data published by Aiuti et al, 40 who reported that chemotaxis in response to SDF-1␣ of normal mobilised CD34 ϩ cells is lower than in NBM CD34 ϩ cells, suggesting that an altered response to SDF-1␣ may be associated with CD34 ϩ HPC mobilisation. The reduced migration response in CML PB CD34
ϩ as compared to LP CD34 ϩ cells could be explained by abnormal integrin-cytoskeletal interactions in CML cells that have been described in a recent report by Bhatia et al. 41 In particular, these authors showed that CML CD34 ϩ cells exhibit a p210 bcr/abl-mediated abnormal association of integrin receptors with the cytoskeleton and restricted receptor mobility as indicated by impaired ␤1 integrin capping in vitro.
In a second set of experiments we compared the chemotactic properties of bcr/abl-positive and -negative cells in chimeric CML CD34 ϩ samples obtained from patients in early chronic phase of the disease. The percentage of bcr/abl-positive and -negative cells in the inoculated and migrated cell fractions was identical as analysed by FISH, suggesting comparable SDF-1␣-induced effects in the malignant cell clone and the coexisting normal CD34 ϩ HPC population in the same individual. Clearly, more experiments are needed to confirm these latter results, which could be explained by an inhibitory effect of accessory bcr/abl ϩ cells on the chemotactic responsiveness of bcr/abl − CD34 ϩ cells in the chimeric CML samples. This notion would be consistent with a report by Bhatia et al, 42 who observed that bcr/abl ϩ macrophages inhibit the proliferation of bcr/abl − long-term culture initiating cells (LTCIC) in CML long-term bone marrow cultures (LTBMC).
Our migration data extend and partially contrast a recent study by Salgia et al, 36 who showed that p210 bcr/abl transformed haemopoietic cell lines become refractory to the chemotactic effects of SDF-1␣. Furthermore, the same authors observed an increased spontaneous motility of bcr/abl transformed cells whereas our own results revealed a similar spontaneous migration of normal and CML CD34 ϩ cells. However, these discrepancies can probably be explained by differences in the experimental systems, the most important being the use of different cell sources.
We next determined the effects of SDF-1␣ on colony formation from normal and CML CD34 ϩ cells. Immunomagnetically isolated CD34
ϩ cells were incubated in the presence of various concentrations of the chemokine for 14 days. SDF-1␣ induced a dose-dependent inhibition of colony formation generated from both normal and CML CD34 ϩ cells. Interestingly, while in the normal LP CD34 ϩ controls the SDF-1␣-induced inhibitory effect was largely restricted to the granulomonocytic (CFC-GM) lineage, in the CML group the erythroid (BFU-E) lineage was also affected. SDF-1␣-induced growth-sup-
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؉ cells J Dürig et al 1658 Leukemia pressive effects in the haemopoietic system were first described in the murine 32D cell line model. 43 Using human HPC we have reported, that SDF-1␣ can inhibit colony formation of normal CD34 ϩ HPC. 19 Recent data by the Vancouver group suggests that the inhibitory action of SDF-1␣ on immature adherent progenitor cells in human LTBMC may be due to the inhibition of cell cycle progression. 44 Importantly, the same authors also observed HPC inhibition in NOD/SCID mice transplanted with human cord blood cells after injection of SDF-1␣ in vivo.
By contrast, other recent studies showed either no 45 or stimulatory 46, 47 SDF-1␣ effects on HPC proliferation. The following important differences in the experimental design of these studies may account for these disparities. First, chemokines can have differential effects depending on the source 48 and purity of CD34 ϩ cells used. Immunomagnetic enrichment of CD34
ϩ HPC, as employed in the experiments described here, only yields CD34 ϩ cell products of 80-98% purity, thus accessory cells stimulated by SDF-1␣ may have contributed to the observed results. Similar factors could have played a role in the even more complex systems of LTBMC and the NOD/SCID transplantation model employed by Cashman et al. 44 Second, the stimulatory SDF-1␣ effects on highly purified PB CD34 ϩ cells reported by Lataillade et al 46 could only be observed in conjunction with other stimulatory cytokines, in particular stem cell factor (SCF). Also, the maximal stimulatory SDF-1␣ concentration in these experiments was 0.05 ng/ml whereas a further concentration increase to 10 ng/ml resulted in reduced potentiating effects. This indicates a bell-shaped concentration effect curve, that has been previously described for other chemokines. 49 By contrast, in the current clonal assays we used SDF-1␣ concentrations of 50-300 ng/ml and 5637 conditioned medium (which is known to contain G-CSF, GM-CSF, IL-1␤, M-CSF and SCF 38, 50 and rhEPO as a source of stimulatory growth factors.
As a recent report has demonstrated that CXCR-4 expression levels on HPC may correlate with the transmigration response to SDF-1␣, 51 we studied CXCR-4 surface expression on normal and CML CD34 ϩ cells employing a two-colour flow cytometry approach. In line with published data, 23 ,51 the majority of normal CD34 ϩ HPC were found to coexpress CXCR-4. No significant differences between normal and CML CD34 ϩ cells were detected, although inter-individual variation within the cohorts was substantial. Furthermore, regression analysis did not reveal a significant correlation between CXCR-4 expression by normal and CML CD34 ϩ cells and their transmigration response to SDF-1␣. This observation agrees with results published by Honczarenko et al, 52 who showed that CXCR-4 expression levels in developing bone marrow-derived B cells may be disproportionate to their SDF-1␣ responsiveness. Thus, SDF-1␣ responsiveness of CD34 ϩ cells may not be exclusively determined by CXCR-4 expression levels but also intracellular signal transduction events downstream of the receptor.
There is now an accumulating body of evidence that CXCR-4 is up-regulated in the course of normal human B cell lymphopoiesis. 23, 52 Here, we confirm these results by showing that NBM CD34 ϩ /CD10 ϩ pro-B cells and mature NBM CD19 ϩ B cells exhibit significantly higher CXCR-4 expression levels than unfractionated NBM CD34 ϩ cells. Interestingly, the highest CXCR-4 receptor levels on CML CD34
ϩ HPC in this study were measured on CD34 ϩ /CD19 ϩ /CD10 ϩ cells isolated from four CML patients in B lymphoblastic crisis of the disease. In three of these patients, in whom the chemotactic response to SDF-1␣ could be assessed, one patient showed a four-fold increase and the remaining two comparable SDF-1␣-induced migration responses to that of cP CML CD34 ϩ cells. This observation is particularly interesting as others have found that bcr/abl fusion transcript levels in lymphoid CML blasts may be increased over that of cP CML CD34 ϩ cells. 53, 54 Thus, the results presented here, indicate that even a high expression of the bcr/abl protein cannot completely abrogate the SDF-1␣-induced chemotactic effects in these cells. Taken together, the latter findings suggest that the up-modulation of CXCR-4 is closely linked to B lymphopoiesis and may also occur in immature CML cells acquiring a B-lymphoblastic phenotype.
We next sought to study the modulation of CXCR-4 in CML as compared to normal haemopoietic cells. Culture of LP and CML CD34
ϩ cells in the presence of high concentrations of SDF-1␣ resulted in significant down-modulation of CXCR-4 surface levels in these cells. Conversely, incubation of CML CD34 ϩ cells in serum-containing medium induced a significant increase in CXCR-4 surface immunoreactivity, which was associated with an enhanced migration response to SDF-1␣. Similar findings have recently been reported for normal CD34 ϩ , B and T cells. 52, 55, 56 Elegant experiments employing radioiodinated SDF-1␣ molecules and fluorescently labelled CXCR-4 specific MoAb detected by confocal microscopy have shown that SDF-1␣-induced CXCR-4 co-internalisation may be a significant component of the mechanism. 55, 56 Following ligand-receptor binding CXCR-4 appears to be internalized through coated pits and coated vehicles and subsequently localise in endosomal compartments from where it can recycle to the cell surface. However, CXCR-4 down-regulation can also be observed in the presence of phorbol esters 55 and following activation of T and B cell receptors [57] [58] [59] suggesting the existence of several distinct internalization signals. Comparably little is known about the up-modulation of CXCR-4 in CD34 ϩ HPC. SCF, 23 IL-6 and as yet undefined serum components 26 have been found to increase CXCR-4 expression levels in human CD34 ϩ cells, but the signal transduction pathways mediating this effect remain to be determined.
Finally, we tried to further define the signal transduction events associated with the binding of SDF-1␣ to its receptor on normal as compared to CML CD34 ϩ cells. SDF-1␣-CXCR-4 binding has been previously shown to induce transient elevations of intracellular calcium levels, 21 ,31,52 which has been used as an indicator of receptor activation. SDF-1␣ was found to be a potent mobilizer of intracellular free calcium in both normal and CML CD34 ϩ cells indicating that CXCR-4 is functionally active in CML cells and able to couple to G-protein signalling mechanisms. Notably, also the kinetics and doseresponse characteristics observed in normal CD34 ϩ cells and their bcr/abl ϩ counterparts were remarkably similar, suggesting comparable initial SDF-1␣-induced signal transduction events in normal and CML HPC. Other signal transduction pathways further downstream of the receptor have only been partially elucidated. [60] [61] [62] In summary, our data suggest a moderately reduced SDF-1␣ migration response in CML CD34 ϩ cells. However, CML and normal CD34 ϩ cells appear to be remarkably similar in terms of SDF-1␣-induced colony inhibition, CXCR-4 expression and its regulation in the presence of SDF-1␣ and serum. These results in combination with the calcium flux experiments indicate the presence of a functional SDF-1␣ receptor in CML CD34
ϩ cells and suggest that SDF-1␣ signalling pathways are not completely uncoupled in these cells.
